Alli bottles tampered with in US, drug recalled
March 27, 2014Manufacturing and Production, Sales and Marketing Alli, FDA, GSK, Roche, Xenical, obesity, weight loss
GlaxoSmithKline has admitted that some bottles of its weight-loss drug Alli bought in the US have been tampered with. US …
GSK and partners set up big data project
March 27, 2014Medical Communications, Research and Development, Sales and Marketing Big Data, European Bioinformatics Institute, GSK, Wellcome Trust Sanger Institute, cttv
GlaxoSmithKline, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute have come together to launch an open access research …
NICE launches VBA consultation
March 27, 2014Sales and Marketing Dillon, England, NHS, NICE, VBP, catchpole, pars, vba
NICE has today launched its consultation into how value-based assessment of drugs will work in practice, which will run for …
Immunocore chief executive cements role at Adaptimmune
March 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, immunocore, noble
Biotech firm Adaptimmune has confirmed the full-time appointment of James Noble as its chief executive. Noble has been chief executive …
Adaptimmune wins fund payout
March 26, 2014Research and Development, Sales and Marketing Adaptimmune, Cancer, T cell, biomedical, noble, sme
Biotech firm Adaptimmune has been awarded £2.1 million from the UK government’s Biomedical Catalyst Fund, which was set up to …
UK government launches ‘Sign up to Safety’ initiative
March 26, 2014Sales and Marketing Francis, Hunt, Mid Staffs, NHS, safety, sign up
A new ambition to reduce avoidable harm in the NHS by half over the next three years, cut costs and …
Pfizer’s Xalkori impresses in new setting
March 26, 2014Research and Development, Sales and Marketing NHS, NICE, NSCLC, Pfizer, Xalkori, lung cancer
Pfizer’s lung cancer treatment Xalkori has proven better at treating patients in a first-line setting when compared to chemotherapy. This …
J&J appoints chief design officer
March 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ernesto Quinteros, J&J, JJ, belkin, design
Johnson & Johnson has reached outside of its industry and into the design and technology realm with its latest appointment. …
FDA unconvinced on Novartis heart drug
March 26, 2014Research and Development, Sales and Marketing FDA, Novartis, ahf, heart, serelaxin
The prospects of Novartis’ latest heart drug being approved in the US anytime soon appear to have been scuppered by …
EFPIA hires director of European affairs
March 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, kuiper
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed Elizabeth Kuiper to be the director of its European …
Parexel expands international operation
March 25, 2014Manufacturing and Production, Sales and Marketing Parexel, Singapore, manufacturing
Biopharma services provider Parexel International Corporation is beefing up its global capacity and adding more secondary packaging and labelling services …
Xolair gets FDA approval for skin condition
March 24, 2014Research and Development, Sales and Marketing FDA, Novartis, Roche, Sanofi, Xolair, chronic hives, csu
An asthma drug developed by Roche subsidiary Genentech and Novartis has been granted an additional indication to treat chronic hives …
CHMP recommends Jardiance
March 24, 2014Research and Development, Sales and Marketing Boehringer, CHMP, EU, diabetes, jardiance, lilly
Boehringer Ingelheim and Eli Lilly’s type 2 diabetes treatment Jardiance is among nine medicines which the Committee for Medicinal Products …
Endocyte lung cancer drug shows promise
March 24, 2014Research and Development, Sales and Marketing Endocyte, MSD, NSCLC, lung cancer, vintafolide
Endocyte and partner MSD have released positive mid-stage trial results for their investigational lung cancer drug vintafolide. The treatment met …
NICE says ‘no’ to Xofigo
March 24, 2014Sales and Marketing Bayer, CDF, NHS, NICE, abiraterone, prostate, xofigo
NICE has dealt Bayer a severe blow by not approving prostate cancer drug Xofigo for use on the NHS in …
Former Google head to lead comms for M3

March 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cowderoy, doctors.net, google, m3
Healthcare information provider M3 has appointed the former head of healthcare at Google as its managing director of communications in …
Data transparency debate: Europe decides its future
March 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency
Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
